The cost of the American Gene Technologies® gene therapy has not yet been established because the therapy is still in development. However, we expect the cost to be similar to “CAR T” therapies currently on the market. Our goal is to create a cure for HIV that is accessible and affordable for all. The first step is to demonstrate a safe, effective, and broadly applicable therapeutic. The next step will be to engineer economic efficiency into the manufacturing process. Whatever the initial price might be, it will decrease over time as we achieve production and distribution efficiencies. New inventions are affected by the same “technology curve” that turned giant expensive mainframe computers into compact, affordable notebook computers and smartphones. In the same way, successive iterations should drive costs down even as the technology improves.